BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 15714385)

  • 1. Progesterone receptor antagonists and selective progesterone receptor modulators (SPRMs).
    Spitz IM
    Semin Reprod Med; 2005 Feb; 23(1):3-7. PubMed ID: 15714385
    [No Abstract]   [Full Text] [Related]  

  • 2. Mechanisms controlling agonist and antagonist potential of selective progesterone receptor modulators (SPRMs).
    Wardell SE; Edwards DP
    Semin Reprod Med; 2005 Feb; 23(1):9-21. PubMed ID: 15714386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery, chemistry, and reproductive pharmacology of asoprisnil and related 11beta-benzaldoxime substituted selective progesterone receptor modulators (SPRMs).
    Schubert G; Elger W; Kaufmann G; Schneider B; Reddersen G; Chwalisz K
    Semin Reprod Med; 2005 Feb; 23(1):58-73. PubMed ID: 15714390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent patent trends in the field of progesterone receptor agonists and modulators.
    Schmees N; Weinmann H
    Expert Opin Ther Pat; 2009 Nov; 19(11):1521-34. PubMed ID: 19785507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonsteroidal progesterone receptor modulators: structure activity relationships.
    Winneker RC; Fensome A; Wrobel JE; Zhang Z; Zhang P
    Semin Reprod Med; 2005 Feb; 23(1):46-57. PubMed ID: 15714389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The immninent dawn of SPRMs in obstetrics and gynecology.
    Chabbert-Buffet N; Pintiaux A; Bouchard P
    Mol Cell Endocrinol; 2012 Jul; 358(2):232-43. PubMed ID: 22415029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progesterone receptor antagonists and the endometrial antiproliferative effect.
    Brenner RM; Slayden OD
    Semin Reprod Med; 2005 Feb; 23(1):74-81. PubMed ID: 15714391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gynaecological uses of a new class of steroids: the selective progesterone receptor modulators.
    Pintiaux A; Chabbert-Buffet N; Foidart JM
    Gynecol Endocrinol; 2009 Feb; 25(2):67-73. PubMed ID: 19253100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of progesterone antagonists and new selective progesterone receptor modulators in reproductive health.
    Olive DL
    Obstet Gynecol Surv; 2002 Nov; 57(11 Suppl 4):S55-63. PubMed ID: 12454529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Selective progesterone receptor modulators: future clinical applications].
    Bouchard P; Ouzounian S; Chabbert-Buffet N
    Bull Acad Natl Med; 2008; 192(6):1159-71; discussion 1172-3. PubMed ID: 19235480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progesterone receptor antagonists.
    Spitz IM
    Curr Opin Investig Drugs; 2006 Oct; 7(10):882-90. PubMed ID: 17086932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progesterone receptor modulators in gynaecological practice.
    Wilkens J; Critchley H
    J Fam Plann Reprod Health Care; 2010 Apr; 36(2):87-92. PubMed ID: 20406552
    [No Abstract]   [Full Text] [Related]  

  • 13. Selective progesterone receptor modulators (SPRMs): a novel therapeutic concept in endometriosis.
    Chwalisz K; Garg R; Brenner RM; Schubert G; Elger W
    Ann N Y Acad Sci; 2002 Mar; 955():373-88; discussion 389-93, 396-406. PubMed ID: 11949964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Selective progesterone receptor modulators and their therapeutical use].
    Driák D; Sehnal B; Svandová I
    Ceska Gynekol; 2013 Apr; 78(2):175-81. PubMed ID: 23710982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progesterone receptor modulators at the start of a new millennium.
    Spitz IM; Coelingh Bennink HJ
    Steroids; 2000; 65(10-11):837-8. PubMed ID: 11209734
    [No Abstract]   [Full Text] [Related]  

  • 16. Nonsteroidal progesterone receptor ligands (I): synthesis and SAR of new tetrahydronaphthofuranone derivatives.
    Shinei R; Kurihara K; Tanabe K; Tabata Y; Kurata Y; Hoshiko S; Okonogi T
    Bioorg Med Chem; 2006 Jul; 14(14):4850-61. PubMed ID: 16580213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endocrinological properties of two novel nonsteroidal progesterone receptor modulators, CP8816 and CP8863.
    Kurata Y; Tabata Y; Shinei R; Iizuka Y; Masuda NT; Kurihara K; Okonogi T; Hoshiko S
    J Pharmacol Exp Ther; 2005 May; 313(2):916-20. PubMed ID: 15743919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigational developments for the treatment of progesterone-dependent diseases.
    Möller C; Hoffmann J; Kirkland TA; Schwede W
    Expert Opin Investig Drugs; 2008 Apr; 17(4):469-79. PubMed ID: 18363513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Interest of selective progesterone receptor modulators in endometriosis].
    Merviel P; Lourdel E; Sanguin S; Gagneur O; Cabry R; Nasreddine A
    Gynecol Obstet Fertil; 2013 Sep; 41(9):524-8. PubMed ID: 23972920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new generation of progesterone receptor modulators.
    Winneker RC; Fensome A; Zhang P; Yudt MR; McComas CC; Unwalla RJ
    Steroids; 2008 Aug; 73(7):689-701. PubMed ID: 18472121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.